| Business Name: |
Shire Regenerative Medicine Inc |
| Contact Person: |
Jennifer Cassidy |
| Address: |
10933 North Torrey Pines Road, La Jolla, California 92037 |
| Phone Number: |
(858) 202-0673 |
| Annual Revenue (USD): |
Unknown |
| Location Type: |
Branch |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B (Business to Business) |
| Business Category: |
Research and Development Laboratories |
| SIC Code: |
8731 |
| NAICS Code: |
541712 |
| Share This Business: |
|
| Related Businesses: |
Merck Research Labs - La Jolla, CA 92037
Membrane Receptor Technologies - La Jolla, CA 92037
Hls Research Inc - La Jolla, CA 92037
Entropy Control Inc - La Jolla, CA 92037
Cycle Genomics Inc - La Jolla, CA 92037
Genewiz Inc - La Jolla, CA 92037
Geneohm Sciences Inc - La Jolla, CA 92037
Tuna Conference - La Jolla, CA 92037
Thira LLC - La Jolla, CA 92037
San Diego Research - La Jolla, CA 92037
Ampli Prot LLC - La Jolla, CA 92037
Paula Olson - La Jolla, CA 92037
Walter D Niles - La Jolla, CA 92037
Symmunity LLC - La Jolla, CA 92037
Zenobia Therapeutics Inc - La Jolla, CA 92037
Omegagen Inc - La Jolla, CA 92037
Mandala Biosciences LLC - La Jolla, CA 92037
Allimmune LLC - La Jolla, CA 92037
Akkadix Corp - La Jolla, CA 92037
Bio Edge Inc - La Jolla, CA 92037
|
The company Shire Regenerative Medicine Inc provides B2B services in the form of Research and Development Laboratories from its branch in California.
1 to 4 employees work for Shire Regenerative Medicine Inc, and the business now earns Unknown per annum.
Shire Regenerative Medicine Inc was launched in 0 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 .
To contact Shire Regenerative Medicine Inc, please call Jennifer Cassidy with the phone number (858) 202-0673 or visit its branch at 10933 North Torrey Pines Road in La Jolla, California 92037.
The location of the branch can also be found using the coordinates 32.901881,-117.242471.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.